| Name: | Dihydro-α-ergocriptine Mesylate |
|---|
| Formula: | C32H43N5O5 . CH4O3S |
|---|
| CAS: | 29261-93-6 |
|---|
|  |
|---|
| Therapeutic use: | antiparkinson agent, prolactin inhibitor, cerebral vasodilator |
|---|
| Final dosage form types: | tablets, capsules, oral solution |
|---|
| Specification: | internal |
|---|
| Available Documents: | Technical package |
|---|
